CVC Capital Partners related stories
All articles and analysis
PEI Awards 2021: Asia-Pacific winnersKKR takes home the prizes for six different categories for the second consecutive year
Secondaries M&A: Changing of the guardWhile few established secondaries firms remain independent after a glut of M&A transactions last year, more groups than ever are seeking a seat at the table in the expanding marketplace.
Side Letter: PE prices in a crisis; KKR's $4bn addendum; SPACs under attackKey developments in how Russia's invasion of Ukraine is impacting the alternatives industry. Plus: KKR is seeking an additional $4 billion for its latest long-hold fund and why insurers are taking a dim view of SPACs. Here's today's brief, for our valued subscribers only.
Where next for ESG reporting?A high-profile agreement on standardised metrics marks an important first step, but LPs will soon be wanting more.
PE on course for a deeper dive into responsible investingNew collaborations and burgeoning areas of interest will continue to make ESG a growing focus of the industry.
Side Letter: PE's biggest bulls; SEC's second warning shot; Japan's HNW opportunityOur latest investor report finds allocations on the up again, with foundations and endowments leading the charge. Plus: The SEC claims PE's investor communications aren't up to snuff and two fundraising platforms have designs on Japan. Here's today's brief, for our valued subscribers only.
BC Partners eyes 2023 return as it wraps up latest flagship below targetThe London-headquartered firm had sought €8.5bn for its 11th and largest buyout fund.
Side Letter: GP stakes look east; TPG's $9bn IPO; Ares raises $3.3bn – updatedDyal's latest coup in Asia-Pacific could inspire the market's growing pool of GP stakes firms to look east. Plus: TPG has set a price for today's IPO and Ares has gathered $3.3 billion for its latest special opportunities fund. Here's today's brief, for our valued subscribers only.
Secondaries firms for sale, but only while supplies lastFew secondaries firms remain independent after a glut of M&A transactions this year.
Side Letter: PE IPOs; MassPRIM's $1bn co-invest capacity; Primavera's SEA pushWhat's the best way to monetise your management company: stay private and sell to a GP stakes firm, or join the ranks of private equity's listed elite? Plus: the $97 billion MassPRIM wants to double down on private equity co-investments and China's Primavera appears bullish on Southeast Asia. Here's today's brief, for our valued subscribers only.